YC
Ysios Capital
Venture CapitalActiveYsios Capital is the biotechnology venture capital firm in Spain.
49
Investments
4
Exits
$500M
AUM
8.2%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Ysios Capital.
Investment Thesis & Strategy
Ysios Capital invests in various stages of biotechnology companies in Spain, focusing on the biotech sector.
Investment Activity
Deals per year over the last 17 years
2
20060
20072
20080
20090
20100
20110
20120
20130
20141
20152
20162
20170
20180
20190
20202
20211
2022Portfolio Companies
Selected investments from their portfolio of 49 companies
G
Gate2Brain
Biotech · Seed, 2022
S
Splice Bio
Biotech · Seed, 2021
D
DeepUll
Biotech · Series A, 2021
V
Viralgen
Biotech · Growth, 2017
M
Minoryx Therapeutics
Biotech · Series B, 2017
B
Bionure
Biotech · Series A, 2016
S
Sanifit
Biotech · Series B, 2016
A
Aelix Therapeutics
Biotech · Series A, 2015
B
Biofabri
Biotech · Growth, 2008
I
Insud Pharma
Biotech · Growth, 2008
Z
Zealand Pharma
Biotech · Growth, 2006
O
Oryzon Genomics
Biotech · Growth, 2006
Notable Exits
CompanyTypeYearValue / Acquirer
ViralgenAcquisition2023—
TargaceptAcquisition2015—
CellerixAcquisition2013—
Zeus ScientificAcquisition2012—
Frequently Asked Questions
Ysios Capital focuses on Series A, Series B, Series C+ stage investments.